Hua-Qiang Zhou (Huaqiang Zhou)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

NPJ precision oncology

Cancer medicine

Signal transduction and targeted therapy

MedComm

This page only lists publications with an associated author ORCID identifier.

Publications

Hua-Qiang Zhou, Ya-Xiong Zhang, Gang Chen, Qi-Tao Yu, Hua Zhang, Guo-Wu Wu, Di Wu, Ying-Cheng Lin, Jun-Fei Zhu, Jian-Hua Chen, Xiao-Hua Hu, Bin Lan, Ze-Qiang Zhou, Hai-Feng Lin, Zi-Bing Wang, Xiao-Lin Lei, Suo-Ming Pan, Li-Ming Chen, Jian Zhang, Tian-Dong Kong, Ji-Cheng Yao, Xin Zheng, Feng Li, Li Zhang, Wen-Feng Fang
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial. Signal transduction and targeted therapy 9 (1) (2024)
Yuxiang Ma, Hua-Qiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, Zhan Huang, Jingbo Zhao, Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang, Hongyun Zhao
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma. NPJ precision oncology 8 (1) (2024)
Yuxiang Ma, Hua-Qiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, Zhan Huang, Jingbo Zhao, Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang, Hongyun Zhao
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma. NPJ precision oncology 8 (1) (2024)
Hua-Qiang Zhou, Ya-Xiong Zhang, Gang Chen, Qi-Tao Yu, Hua Zhang, Guo-Wu Wu, Di Wu, Ying-Cheng Lin, Jun-Fei Zhu, Jian-Hua Chen, Xiao-Hua Hu, Bin Lan, Ze-Qiang Zhou, Hai-Feng Lin, Zi-Bing Wang, Xiao-Lin Lei, Suo-Ming Pan, Li-Ming Chen, Jian Zhang, Tian-Dong Kong, Ji-Cheng Yao, Xin Zheng, Feng Li, Li Zhang, Wen-Feng Fang
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial. Signal transduction and targeted therapy 9 (1) (2024)
Yuxiang Ma, Hua-Qiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, Zhan Huang, Jingbo Zhao, Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang, Hongyun Zhao
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma. NPJ precision oncology 8 (1) (2024)
Hua-Qiang Zhou, Ya-Xiong Zhang, Gang Chen, Qi-Tao Yu, Hua Zhang, Guo-Wu Wu, Di Wu, Ying-Cheng Lin, Jun-Fei Zhu, Jian-Hua Chen, Xiao-Hua Hu, Bin Lan, Ze-Qiang Zhou, Hai-Feng Lin, Zi-Bing Wang, Xiao-Lin Lei, Suo-Ming Pan, Li-Ming Chen, Jian Zhang, Tian-Dong Kong, Ji-Cheng Yao, Xin Zheng, Feng Li, Li Zhang, Wen-Feng Fang
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial. Signal transduction and targeted therapy 9 (1) (2024)
Wenfeng Fang, Haoxuan Jin, Hua-Qiang Zhou, Shaodong Hong, Yuxiang Ma, Yaxiong Zhang, Xiaofan Su, Longyun Chen, Yunpeng Yang, Shengqiang Xu, Yuwei Liao, Yuming He, Hongyun Zhao, Yan Huang, Zhibo Gao, Li Zhang
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer. Molecular cancer 20 (1) (2021)
Jiayi Shen, Hua-Qiang Zhou, Jiaqing Liu, Zhonghan Zhang, Wenfeng Fang, Yunpeng Yang, Shaodong Hong, Wei Xian, Yuxiang Ma, Ting Zhou, Yaxiong Zhang, Hongyun Zhao, Yan Huang, Li Zhang
Incidence and risk factors of second primary cancer after the initial primary human papillomavirus related neoplasms. MedComm 1 (3) (2020)
Hua-Qiang Zhou, Jiaqing Liu, Yaxiong Zhang, Yan Huang, Jiayi Shen, Yunpeng Yang, Wenfeng Fang, Li Zhang
PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in non-small cell lung cancer. NPJ precision oncology 4 (2020)
Shaodong Hong, Dong-Bing Liu, Shuzhen Luo, Wenfeng Fang, Jianhua Zhan, Sha Fu, Yaxiong Zhang, Xuan Wu, Hua-Qiang Zhou, Xi Chen, Gang Chen, Zhonghan Zhang, Qiufan Zheng, Xiaobo Li, Jinghao Chen, Xingmin Liu, Mengyue Lei, Chen Ye, Jian Wang, Huanming Yang, Xue Liu, Shida Zhu, Yunpeng Yang, Yuanyuan Zhao, Ningning Zhou, Hongyun Zhao, Yan Huang, Lanjun Zhang, Kui Wu, Li Zhang
The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma. Nature communications 10 (1) (2019)
Hua-Qiang Zhou, Jiaqing Liu, Yaxiong Zhang, Li Zhang
Inflammatory bowel disease associated with the combination treatment of nivolumab and metformin: data from the FDA adverse event reporting system. Cancer chemotherapy and pharmacology 83 (3) (2019)
Wenfeng Fang, Yuxiang Ma, Jiani C Yin, Shaodong Hong, Hua-Qiang Zhou, Ao Wang, Fufeng Wang, Hua Bao, Xue Wu, Yunpeng Yang, Yan Huang, Hongyun Zhao, Yang W Shao, Li Zhang
Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti-PD-(L)1 Therapies in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (16) (2019)
Jiaqing Liu, Hua-Qiang Zhou, Yaxiong Zhang, Yan Huang, Wenfeng Fang, Yunpeng Yang, Shaodong Hong, Gang Chen, Shen Zhao, Xi Chen, Zhonghan Zhang, Jiayi Shen, Wei Xian, Jianhua Zhan, Yuanyuan Zhao, Xue Hou, Yuxiang Ma, Ting Zhou, Hongyun Zhao, Li Zhang
Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study. Cancer medicine 8 (4) (2019)
Hua-Qiang Zhou, Yan Huang, Zeting Qiu, Hongyun Zhao, Wenfeng Fang, Yunpeng Yang, Yuanyuan Zhao, Xue Hou, Yuxiang Ma, Shaodong Hong, Ting Zhou, Yaxiong Zhang, Li Zhang
Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database. International journal of cancer 143 (7) (2018)
Hua-Qiang Zhou, Wei Xian, Yaxiong Zhang, Gang Chen, Shen Zhao, Xi Chen, Zhonghan Zhang, Jiayi Shen, Shaodong Hong, Yan Huang, Li Zhang
Trends in incidence and associated risk factors of suicide mortality in patients with non-small cell lung cancer. Cancer medicine 7 (8) (2018)
Hua-Qiang Zhou, Yuanzhe Zhang, Xiaoyue Wei, Kaibin Yang, Wulin Tan, Zeting Qiu, Si Li, Qinchang Chen, Yiyan Song, Shao-Wei Gao
Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study. Cancer medicine 6 (11) (2017)

Hua-Qiang Zhou.css-eqlu8i{font-size:small;padding-left:4px;} (Huaqiang Zhou)

Publication Activity (10 Years)

Top Topics

Top Venues

Hua-Qiang Zhou (Huaqiang Zhou)